1
|
Alshammari NAH, Bakhotmah DA. Synthesis, reactivity, antimicrobial, and anti-biofilm evaluation of fluorinated 4-amino-3-mercapto-1,2,4-triazin-5(4 H)-one and their derivatives. PHOSPHORUS SULFUR 2022. [DOI: 10.1080/10426507.2022.2150856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Affiliation(s)
- Nawaa Ali H. Alshammari
- Department of Chemistry, King Abdulaziz University, Jeddah, Saudi Arabia
- Department of Chemistry, Northern Border University, Rafha, Saudi Arabia
| | - Dina A. Bakhotmah
- Department of Chemistry, King Abdulaziz University, Jeddah, Saudi Arabia
| |
Collapse
|
4
|
Jain AK, Sharma S, Vaidya A, Ravichandran V, Agrawal RK. 1,3,4-thiadiazole and its derivatives: a review on recent progress in biological activities. Chem Biol Drug Des 2013; 81:557-76. [PMID: 23452185 DOI: 10.1111/cbdd.12125] [Citation(s) in RCA: 209] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The 1,3,4-thiadiazole nucleus is one of the most important and well-known heterocyclic nuclei, which is a common and integral feature of a variety of natural products and medicinal agents. Thiadiazole nucleus is present as a core structural component in an array of drug categories such as antimicrobial, anti-inflammatory, analgesic, antiepileptic, antiviral, antineoplastic, and antitubercular agents. The broad and potent activity of thiadiazole and their derivatives has established them as pharmacologically significant scaffolds. In this study, an attempt has been made with recent research findings on this nucleus, to review the structural modifications on different thiadiazole derivatives for various pharmacological activities.
Collapse
Affiliation(s)
- Abhishek Kumar Jain
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, Madhya Pradhesh, India.
| | | | | | | | | |
Collapse
|
6
|
Xiao D, Palani A, Sofolarides M, Aslanian R, West RE, Williams SM, Wu RL, Hwa J, Sondey C, Lachowicz J, Korfmacher WA. Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonists. Bioorg Med Chem Lett 2012; 22:3354-7. [DOI: 10.1016/j.bmcl.2012.02.076] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2012] [Revised: 02/18/2012] [Accepted: 02/23/2012] [Indexed: 01/08/2023]
|
7
|
Rao AU, Shao N, Aslanian RG, Chan TY, Degrado SJ, Wang L, McKittrick B, Senior M, West RE, Williams SM, Wu RL, Hwa J, Patel B, Zheng S, Sondey C, Palani A. Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetes. ACS Med Chem Lett 2012; 3:198-202. [PMID: 24900450 DOI: 10.1021/ml200250t] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2011] [Accepted: 11/20/2011] [Indexed: 12/31/2022] Open
Abstract
A series of novel 2-piperidinopiperidine thiadiazoles were synthesized and evaluated as new leads of histamine H3 receptor antagonists. The 4-(5-([1,4'-bipiperidin]-1'-yl)-1,3,4-thiadiazol-2-yl)-2-(pyridin-2-yl)morpholine (5u) displayed excellent potency and ex vivo receptor occupancy. Compound 5u was also evaluated in vivo for antidiabetic efficacy in STZ diet-induced obesity type 2 diabetic mice for 2 or 12 days. Non-fasting glucose levels were significantly reduced as compared with vehicle-treated mice. In addition, 5u dose dependently blocked the increase of HbA1c after 12 days of treatment.
Collapse
Affiliation(s)
- Ashwin U. Rao
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Ning Shao
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Robert G. Aslanian
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Tin-Yau Chan
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Sylvia J. Degrado
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Li Wang
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Brian McKittrick
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Mary Senior
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Robert E. West
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Shirley M. Williams
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Ren-Long Wu
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Joyce Hwa
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Bhuneshwari Patel
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Shuqin Zheng
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Christopher Sondey
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| | - Anandan Palani
- Department
of Medicinal Chemistry and ‡Cardiovascular/Metabolic Disease, Merck Research Laboratories, 2015 Galloping Hill Road,
Kenilworth, New Jersey 07033, United States
| |
Collapse
|